Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase III Trial of Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions in Older Women With Early-Stage Breast Cancer (POWER II)

NCT06507618 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06507618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06507618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase III Trial of Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions in Older Women With Early-Stage Breast Cancer (POWER II)
Lead sponsor
University of Virginia
Phase
Phase 3
Overall status
Recruiting
Start date
July 19, 2024
Completion date
March 1, 2034
Enrollment
354 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female